Plasma Cell Leukemia

Showing 1 - 25 of 31

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • VRD-based regimen
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Aug 4, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 13, 2023

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • (no location specified)
Apr 10, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • CT0594CP
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Apr 18, 2023

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Plasma Cell Leukemia
  • CAR-T (CAR-GPRC5D)
  • (no location specified)
Feb 26, 2023

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia Trial in Birmingham

Recruiting
  • Multiple Myeloma
  • +2 more
    • Birmingham, Alabama
      Kirklin Clinic of UAB Hospital
    Sep 22, 2022

    Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

    Active, not recruiting
    • Plasma Cell Leukemia
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Plasma Cell Leukemia
    • CAR-T (CAR-GPRC5D)
    • Wuhan, Hu Bei, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    May 17, 2022

    Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

    Active, not recruiting
    • Plasma Cell Leukemia
    • +2 more
    • Rochester, Minnesota
    • +1 more
    May 19, 2022

    A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

    Recruiting
    • Multiple Myeloma
    • +11 more
    • No intervention
    • Beijing, China
      Peking University First Hospital
    Apr 21, 2022

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)

    Available
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • (no location specified)
    Mar 28, 2022

    Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

    Active, not recruiting
    • Autologous Hematopoietic Stem Cell Transplant Recipient
    • +4 more
    • Duarte, California
      City of Hope
    Mar 17, 2022

    Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill

    Recruiting
    • Multiple Myeloma
    • +8 more
      • Chapel Hill, North Carolina
        North Carolina Cancer Hospital
      Nov 30, 2021

      Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

      Recruiting
      • Acute Leukemia
      • +24 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Nov 4, 2021

      Plasma Cell Leukemia Trial (Daratumumab)

      Not yet recruiting
      • Plasma Cell Leukemia
      • (no location specified)
      Sep 22, 2021

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

      Recruiting
      • Acute Myelogenous Leukemia
      • +17 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      May 21, 2021

      Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma Trial in Durham, Portland (procedure, drug, other)

      Completed
      • Plasma Cell Leukemia
      • Recurrent Plasma Cell Myeloma
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +9 more
      • Durham, North Carolina
      • +1 more
      Nov 19, 2020

      Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Carfilzomib, Filanesib,

      Completed
      • Plasma Cell Leukemia
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 12, 2019

      Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Plasmacytoma Trial in Tianjin (Allogeneic Hematopoietic Stem Cell

      Unknown status
      • Multiple Myeloma
      • +8 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +5 more
      • Tianjin, Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      Jul 3, 2019

      B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p Trial in Seattle, Milwaukee (procedure, drug, other,

      Completed
      • B-Cell Prolymphocytic Leukemia
      • +20 more
      • Allogeneic Bone Marrow Transplantation
      • +14 more
      • Seattle, Washington
      • +1 more
      May 31, 2019